M. Lans

538 total citations
30 papers, 437 citations indexed

About

M. Lans is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, M. Lans has authored 30 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in M. Lans's work include Drug Transport and Resistance Mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). M. Lans is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). M. Lans collaborates with scholars based in Belgium and Sweden. M. Lans's co-authors include Marcel Roberfroid, Henryk Taper, H Taper, Véronique Préat, Marcel Roberfroid, J. L. Michaux, Magda Opsomer, I.M. Bruggeman, R.M.E. Vos and Peter J. van Bladeren and has published in prestigious journals such as Blood, Cancer and International Journal of Cancer.

In The Last Decade

M. Lans

29 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Lans Belgium 13 212 107 92 75 62 30 437
Masahiko Sunaga Japan 13 233 1.1× 82 0.8× 32 0.3× 123 1.6× 59 1.0× 25 491
Keisuke Ozaki Japan 15 291 1.4× 154 1.4× 41 0.4× 123 1.6× 32 0.5× 42 677
Pamela DeLuca United States 8 354 1.7× 45 0.4× 67 0.7× 210 2.8× 91 1.5× 10 574
Erdoğan Ertürk United States 12 165 0.8× 77 0.7× 43 0.5× 108 1.4× 56 0.9× 17 467
Randall Rago United States 10 247 1.2× 107 1.0× 40 0.4× 112 1.5× 32 0.5× 18 526
Hirofumi Oka Japan 8 189 0.9× 47 0.4× 57 0.6× 76 1.0× 236 3.8× 13 552
Giovanni Battista Gabrielli Italy 13 143 0.7× 41 0.4× 74 0.8× 43 0.6× 33 0.5× 32 498
Hiroshi Fukui Japan 9 112 0.5× 33 0.3× 82 0.9× 113 1.5× 54 0.9× 15 422
Massimo Casaril Italy 13 165 0.8× 45 0.4× 143 1.6× 42 0.6× 34 0.5× 34 567
Fengyun Dong China 17 235 1.1× 78 0.7× 61 0.7× 130 1.7× 42 0.7× 25 612

Countries citing papers authored by M. Lans

Since Specialization
Citations

This map shows the geographic impact of M. Lans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lans more than expected).

Fields of papers citing papers by M. Lans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Lans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lans. The network helps show where M. Lans may publish in the future.

Co-authorship network of co-authors of M. Lans

This figure shows the co-authorship network connecting the top 25 collaborators of M. Lans. A scholar is included among the top collaborators of M. Lans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Lans. M. Lans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lans, M., Eva Klasson‐Wehler, & Abraham Brouwer. (1994). Thyroid hormone binding proteins as targets for hydroxylated PCB, PCDD and PCDF metabolites; an overview.. Socio-Environmental Systems Modeling. 20. 481–485. 2 indexed citations
2.
Lans, M., et al.. (1993). Different effects of 2,3,7,8-tetrachloridibenzo-p-dioxin and Aroclor 1254 on thyroxine metabolism and transport.. Socio-Environmental Systems Modeling. 13. 137–140. 1 indexed citations
3.
Lans, M., et al.. (1993). Serum alkaline deoxyribonuclease activity, a sensitive marker for the therapeutic monitoring of cancer patients: methodological aspects.. PubMed. 31(11). 793–7. 14 indexed citations
4.
Roullet, Bernard, M Labadie, Henryk Taper, et al.. (1990). Valeur prédictive des variations de l'activité sérique de la DNAse alcaline dans le pronostic des cancers des voies aérodigestives supérieures traités par chimiothérapie.. Bulletin du Cancer. 77(7). 675–680. 1 indexed citations
5.
Opsomer, Magda, et al.. (1990). Predictive Value of Serum Alkaline Dnase Activity Variations in Treatment of Head and Neck Cancer. Acta Oncologica. 29(2). 163–166. 12 indexed citations
6.
Åvall‐Lundqvist, E., K. Sjövall, M. Lans, et al.. (1989). Serum alkaline DNase activity in normal or nonhospitalised individuals. Clinica Chimica Acta. 185(1). 35–43. 23 indexed citations
7.
Bruggeman, I.M., et al.. (1989). Use of monolayers of primary rat kidney cortex cells for nephrotoxicity studies. Toxicology in Vitro. 3(4). 261–269. 23 indexed citations
8.
Brasseur, Francis, et al.. (1989). Variations in serum alkaline dnase activity in rats during growth and treatment of tumors sensitive or resistant to therapy. International Journal of Cancer. 43(5). 956–959. 16 indexed citations
9.
10.
11.
Lans, M., et al.. (1988). variations in serum alkaline dnase activity. A new means for therapeutic monitoring of malignant lymphomas. Cancer. 61(9). 1838–1843. 31 indexed citations
12.
Taper, Henryk, et al.. (1988). Histochemical detection of the in vivo produced cellular aldehydes by means of direct Schiff's reaction in CCl4 intoxicated rat liver. Archives of Toxicology. 61(5). 406–410. 13 indexed citations
13.
Opsomer, Magda, et al.. (1988). Characteristic variations of serum alkaline DNase activity in relation to response to therapy and tumor prognosis in human lung cancer. European Journal of Cancer and Clinical Oncology. 24(8). 1337–1343. 15 indexed citations
14.
Taper, Henryk, et al.. (1987). Non‐toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pre‐treatment. International Journal of Cancer. 40(4). 575–579. 89 indexed citations
15.
Taper, H, et al.. (1987). Dietary modulation of rat liver carcinogenesis. Carcinogenesis. 8(2). 337–340. 5 indexed citations
16.
17.
Préat, Véronique, et al.. (1986). Influence of the nature and the dose of the initiator on the development of premalignant and malignant lesions in rat hepatocarcinogenesis. Teratogenesis Carcinogenesis and Mutagenesis. 6(3). 165–172. 8 indexed citations
18.
Préat, Véronique, et al.. (1986). Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis.. PubMed. 77(7). 629–38. 16 indexed citations
19.
Lans, M., et al.. (1983). Phenobarbital as a promoter in the initiation/selection process of experimental rat hepatocarcinogenesis. Carcinogenesis. 4(2). 141–144. 49 indexed citations
20.
Verschueren, Hendrik, et al.. (1982). Premalignant Rat-liver Nodule Cells in Culture. Biology of the Cell. 45. 51–51. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masahiko Sunaga Breakdown of academic impact, for papers by Keisuke Ozaki Breakdown of academic impact, for papers by Pamela DeLuca Breakdown of academic impact, for papers by Erdoğan Ertürk Breakdown of academic impact, for papers by Randall Rago Breakdown of academic impact, for papers by Hirofumi Oka Breakdown of academic impact, for papers by Giovanni Battista Gabrielli Breakdown of academic impact, for papers by Hiroshi Fukui Breakdown of academic impact, for papers by Massimo Casaril Breakdown of academic impact, for papers by Fengyun Dong
Rankless by CCL
2026